ArticleJournal of the American Society of Nephrology : JASN2025

Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Jonathan Barratt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.